What's New

Medical News
& Alerts

Conferences
& Meetings


Other Medical
Resources

Employment
Opportunities

Partnering
Opportunities

Search results for: CYTOGEN
95%DGNews: ProstaScint, Prostate Cancer Imaging Product Licensed by FDA
95%DGNews: ProstaScint Recommended by the FDA for Prostate Cancer Patient
94%DGNews: Quadramet Receives FDA Clearance For Severe Bone Cancer Pain
94%DGNews: Agreement Signed for Activated Cell Therapy Product
93%DGNews: RSNA: Comidex Contrast Agent Distinguishes Malignant From Normal Lymph Nodes
92%DGNews: Cytogen Launches First Oral Liquid Formulation of Hormonal Therapy for Breast Cancer Patients
92%DGNews: Cytogen Announces Presentation of Promising Data From Combination Trials With QUADRAMET(R) and Docetaxel in Patients With Hormone Refractory Prostate Cancer
92%DGNews: Cytogen Corporation Launches DRAXIS Health, Inc.'s BrachySeed Palladium-103 Product in the U.S. for Treatment of Prostate Cancer
89%DGNews: ProstaScint More Effective At Detecting Prostate Cancer Metastases
89%DGNews: New Treatment Relieves Bone Pain Caused By Advanced Cancer
88%DGNews: Quadramet (Samarium) Promising New Treatment Option For Osteosarcoma
88%DGNews: Quadramet Receives Canadian Approval For Bone Pain
87%DGNews: Drug Brings Relief From Bone Pain Of Metastatic Breast Cancer and Prostate Cancer
86%DGNews: FDA Approves BrachySeed Pd-103 (Palladium-103 Implant) for Localized Prostate Cancer Tumours
85%DGNews: Investigational New Drug Combidex (Ferumoxtran-10) Useful In Detecting The Spread Of Cancer To Lymph Nodes
85%DGNews: Prostascint Helps Pinpoint Recurrence Of Prostate Cancer After Prostatectomy
81%DGNews: Combination of High Dose Samarium Sm-153 Lexidronam Injection and Chemotherapy Shows Promise for Treatment of High-Risk Acute Myeloid Leukemia
76%DGNews: Capromab Pendetide Imaging Leads to 91.7% Long-Term Disease-Free Survival for Prostate Cancer Patients: Presented at PCS
76%DGNews: Newly Published Clinical Data Demonstrates Activity of Quadramet (samarium Sm-153 lexidronam injection) in Osteosarcoma
75%DGNews: Journal Article Reports New Data Regarding Administration of Quadramet(R) (Samarium Sm-153 Lexidronam Injection) with Chemotherapy in Hormone Refractory Prostate Cancer Patients
74%DGNews: Positive Findings from Clinical Studies of Quadramet in Prostate Cancer Patients With Metastatic Bone Diseas
73%DGNews: AUA: Imaging Agent, ProstaScint (Capromab Penetidine), Identifies Recurrent Prostate Cancer Earlier
Enter keywords you wish to find information about:

Search for documents that contain:
any of these words.
this exact phrase.
all of these words.

 

 

This site is maintained by webmaster@pslgroup.com
Please contact us with any comments, problems or bugs.

All contents Copyright (c) 1998 PSL Consulting Group Inc.
all rights reserved.